(Press-News.org) SEATTLE – Economic findings were released today on the Women's Health Initiative (WHI), estrogen plus progestin (E+P) trial. The WHI is one of the largest National Institutes of Health-funded studies ever conducted on women. Housed at the Fred Hutchinson Cancer Research Center in Seattle, it is a 15-year, multimillion-dollar study established in 1991, involving more than 160,000 women nationwide, including some 3,500 in Washington.
The overall economic return from the WHI E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published, providing a return of approximately $140 on every dollar invested in the trial.
The findings, published today in the Annals of Internal Medicine, are the result of collaboration between WHI investigators and faculty at the Hutchinson Institute for Cancer Outcomes Research. The researchers created a disease simulation model to evaluate clinical and economic outcomes for combined hormone therapy (cHT) eligible women since the initial publication of the E+P trial results in 2003.
The study first estimated clinical outcomes for women taking cHT following the study versus a counterfactual scenario where the E+P trial was not conducted and cHT use persisted at historical (pre-2003) trends. Based on the projected clinical outcomes, the study then calculated the net economic return of the trial, less the trial cost.
During the 10 years following publication of WHI E+P findings, the investigators estimated that 4.3 million fewer women used cHT. As a result there were 126,000 fewer breast cancer cases, 76,000 fewer cardiovascular events, 263,000 more osteoporotic fractures, and 15,000 more colorectal cancer cases compared to the no trial scenario. The observed reduction in cHT prescribing saved $49.5 billion in direct medical care costs. In addition, the net health yield for women in the U.S. was approximately 145,000 more quality-adjusted life years than would have occurred in absence of the trial. Assuming that 75% of the change in cHT prescribing can be directly attributed to the WHI, and subtracting the cost of the study itself ($260 million) the net economic return of WHI E+P trial was $37.1 billion.
"The WHI trial is often discussed as having a major impact on post-menopausal combined hormone therapy use, but I'm not aware of any other studies that have projected how many fewer women used combined hormone therapy as a result of the trial," said Joshua Roth, Ph.D., MHA, Hutchinson Institute for Cancer Outcomes Research, and lead author of the study. "It really brings the point home when you crunch the numbers, to see that millions of U.S. women likely stopped or never used combined hormone therapy based on the trial's findings, and that the change in use resulted in important reductions in disease incidence and associated medical spending."
Of the $37.1 billion in net economic return attributable to the WHI E+P trial, $26.4 billion was attributable to medical expenditure savings. These savings were driven by 25 million fewer person-years of cHT use, as well as cost savings from avoided diseases. The remaining $10.7 billion represents the value of additional quality-adjusted life expectancy resulting from lower incidence of breast cancer, cardiovascular disease, and venous thromboembolism.
"The motivation for the first WHI trial was to see if we could prevent heart disease, the number one killer of women. That's why we did it - the economics never occurred to me," said Garnet Anderson, Ph.D., lead Women's Health Initiative investigator and director of Fred Hutchinson Cancer Research Center's Public Health Sciences Division. "What these findings underscore is the significant role clinical trials play in science and the importance of continuing to find ways to strategically invest public research funds to maximize value to society."
The WHI E+P clinical trial was funded by the National Heart, Lung, and Blood Institute (NHLBI), and its success was realized by dedicated study participants who contributed their time to help answer important research questions. Today's report on the $37.1 billion economic return of its E+P trial suggests that large public research investments can yield considerable clinical and economic value when targeted to address research questions with high clinical relevance and public health impact.
"It is important to consider the potential value of studies when making decisions about how to invest limited public research dollars," said Scott Ramsey, M.D., Ph.D., Director of Hutchinson Institute for Cancer Outcome Research. "Many stakeholders have talked about the high cost of the WHI estrogen plus progestin trial, but few have considered the potential value of the trial. These findings show that the trial was a high-value use of public funds with a substantial return on investment."
INFORMATION:
The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, and the U.S. Department of Health and Human Services.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch's pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation's first and largest cancer prevention research program, as well as the clinical coordinating center of the Women's Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit http://www.fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.
Contact
Michael Nank
Media Relations Manager
206-667-2210 (O)
206-465-6338 (C)
mnank@fredhutch.org
Rhonda Curry
Director of Communications
206-667-1455 (O)
206-240-6011 (C)
rcurry@fredhutch.org
WHI reports $37.1B economic return on combined hormone therapy clinical trial
Researchers at Fred Hutchinson Cancer Research Center demonstrate high-value investment of public funds has substantial economic return
2014-05-06
ELSE PRESS RELEASES FROM THIS DATE:
Novel antioxidant makes old arteries seem young again, CU-Boulder study finds
2014-05-06
An antioxidant that targets specific cell structures—mitochondria—may be able to reverse some of the negative effects of aging on arteries, reducing the risk of heart disease, according to a new study by the University of Colorado Boulder.
When the research team gave old mice—the equivalent of 70- to 80-year-old humans—water containing an antioxidant known as MitoQ for four weeks, their arteries functioned as well as the arteries of mice with an equivalent human age of just 25 to 35 years.
The researchers believe that MitoQ affects the endothelium, a thin layer of cells ...
Cataract surgery decreases risk of falls in older patients
2014-05-06
Orlando, Fla. — New research finds that cataract surgery dramatically decreases the number of falls individuals suffer due to poor vision. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla.
In a study of more than 400 Vietnamese patients who were 50-plus years old with cataracts in both eyes, the number of falls patients suffered before and after cataract surgery was monitored. Researchers found a 78% decrease in the risk of falls the year after patients had cataract ...
Simulated model of eye's 3D structure facilitates stem cells transplant
2014-05-06
Orlando, Fla. — Scientists have developed a model that mimics the complex structure of the cornea to enable the transplant of healthy corneal stem cells. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando Fla.
Used to restore sight, corneal stem cells live in a specific physical environment. Transplanting these stem cells requires accurate mimicry of their natural surroundings during transport. In this work, vision scientists have recreated the 3D architecture where corneal ...
Astronomers harness the galaxy's biggest telescope
2014-05-06
An international team of astronomers has made a measurement of a distant neutron star that is one million times more precise than the previous world's best.
The researchers were able to use the interstellar medium, the 'empty' space between stars and galaxies that is made up of sparsely spread charged particles, as a giant lens to magnify and look closely at the radio wave emission from a small rotating neutron star.
This technique yielded the highest resolution measurement ever achieved, equivalent to being able to see the double-helix structure of our genes from the ...
A novel transgenic mouse model of Chinese Charcot-Marie-Tooth disease type 2L
2014-05-06
Dr. Ruxu Zhang and colleagues from Third Xiangya Hospital, Central South University in China previously found that the K141N mutation in heat shock protein B8 (HSPB8) was responsible for Charcot-Marie-Tooth disease type 2L in a large Chinese family. Therefore, they generated a transgenic mouse model bearing the K141N mutation in the human HSPB8 gene, and to determine whether this K141NHSPB8 transgenic mouse model would manifest the clinical phenotype of Charcot-Marie-Tooth disease type 2L, and consequently be suitable for use in studies of disease pathogenesis. The K141NHSPB8 ...
Regulatory effects of glial cells on retinal synaptic plasticity
2014-05-06
Different types of retinal damage could induce plastic changes of retinal synapses, which might precede the serious damage of neuron soma. These morphological and functional changes to synapses after retinal injury could explain why many intervention measures protected neurons from death but failed to fully recover the damaged visual function. Therefore, it is necessary to investigate both the protection of synapses as well as protecting neurons from death. Dr. Lihong Zhou and co-workers from Central South University in China suggested that retinal glial cell activation ...
The Pael-R gene does not mediate the changes in rotenone-induced PD model cells
2014-05-06
Currently, the pathogenesis of Parkinson's disease is not entirely clear, but it has been generally considered to be the result of interactions among various genetic and environmental factors. Ting Zou and coworkers from Second Xiangya Hospital, Central South University in China previously found that Parkin mutation causes Parkin-associated endothelin receptor-like receptor (Pael-R) protein deposition, and the associated cytotoxicity leads to dopaminergic neuronal apoptosis. These researchers speculated that the Pael-R gene is possibly involved in the action of rotenone ...
AMPK and inflammatory mediators are involved in postoperative cognitive dysfunction
2014-05-06
Postoperative cognitive dysfunction is associated with neuronal apoptosis, which may result from post-surgery inflammation, the phosphorylation of tau protein and the accumulation of amyloid in aged people. 5′adenosine monophosphate-activated protein kinase (AMPK) can be involved in anti-inflammation, neuronal repair and anti-inflammation of the body through different downstream proteins and pathways. In addition, the activation of AMPK regulates tau protein phosphorylation and reduces amyloidogenesis in neurons. Yanlin Bi and co-workers from the Affiliated Qianfoshan ...
Danish social workers have become the moral agents of the state
2014-05-06
"We are turning the professional social workers into moral agents. This development recalls a time before the welfare state, when we had poor relief and when the extent to which the state could help you depended on your own dignity."
This is the assertion by Marie Østergaard Møller, who is associate professor at the Department of Political Science and Government, Aarhus University regarding the labour market policy that has been carried out in Denmark since the 1990s. More specifically, since 1994 the opportunities for citizens to get relief from the state have been reduced. ...
Hotspots of climate change impacts in Africa: Making sense of uncertainties
2014-05-06
Overlapping impacts of climate change such as drought or flooding, declining crop yields or ecosystem damages create hotspots of risk in specific parts of Africa. These are for the first time identified in a study now published by the Potsdam Institute for Climate Impact Research. The uncertainties in assessing the impacts do not necessarily hamper but can inform development strategies, according to the scientists. Likelihood and potential severity of impacts can be weighed to decide on suitable adaptation measures.
"We found three regions to be amongst those most at ...
LAST 30 PRESS RELEASES:
New research boosts future whooping cough vaccines
Mechanistic understanding could enable better fast-charging batteries
No bones about it: new details about skeletal cell aging revealed
UNM scientists discover how nanoparticles of toxic metal used in MRI scans infiltrate human tissue
UMaine research examines best methods for growing Atlantic sea scallops
Medical cannabis could speed recovery, especially at community recovery homes
Study assesses U.S. image amid weakening of democracy
Two scientific researchers to receive 2025 Ralph L. Sacco Scholarships for Brain Health
Researchers improve chemical reaction that underpins products from foods to fuels
Texas Tech to develop semiconductor power devices through $6 million grant
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
Hot Schrödinger cat states created
How cells repair their power plants
Oxygen is running low in inland waters—and humans are to blame
ACP’s Best Practice Advice addresses use of cannabis, cannabinoids for chronic noncancer pain
Beyond photorespiration: A systematic approach to unlocking enhanced plant productivity
How a small number of mutations can fuel outbreaks of western equine encephalitis virus
Exposure to wildfire smoke linked with worsening mental health conditions
Research uncovers hidden spread of one of the most common hospital-associated infections
Many older adults send their doctors portal messages, but who pays?
Fine particulate matter from 2020 California wildfires and mental health–related emergency department visits
Gender inequity in institutional leadership roles in US academic medical centers
Pancreatic cells ‘remember’ epigenetic precancerous marks without genetic sequence mutations
Rare combination of ovarian tumors found in one patient
AI-driven clinical recommendations may aid physician decision making to improve quality of care
Artificial intelligence has potential to aid physician decisions during virtual urgent care
ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025
New study reveals polymers with flawed fillers boost heat transfer in plastics
Signs identified that precede sudden arrhythmic death syndrome in young people
Discovery of bacteria's defence against viruses becomes a piece of the puzzle against resistance
[Press-News.org] WHI reports $37.1B economic return on combined hormone therapy clinical trialResearchers at Fred Hutchinson Cancer Research Center demonstrate high-value investment of public funds has substantial economic return